BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19484952)

  • 41. [The early warning and prognostic value of serum soluble TREM-1 for active pulmonary tuberculosis].
    Zeng J; Kong B; Xiang W; Gao Y; Lu Y; Wang W; Zhang J; Lin D; Liu G; Xu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):235-8. PubMed ID: 25652867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early elevated levels of soluble triggering receptor expressed on myeloid cells-1 in subarachnoid hemorrhage patients.
    Sun XG; Ma Q; Jing G; Wang L; Hao XD; Wang GQ
    Neurol Sci; 2017 May; 38(5):873-877. PubMed ID: 28229304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Levels of soluble triggering receptor expressed on myeloid cells 1 in infectious exacerbations of chronic obstructive pulmonary disease.
    Rohde G; Radsak MP; Borg I; Buhl R; Schultze-Werninghaus G; Taube C
    Respiration; 2012; 83(2):133-9. PubMed ID: 21701149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does soluble triggering receptor expressed on myeloid cells-1 play any role in the pathogenesis of septic shock?
    Routsi C; Giamarellos-Bourboulis EJ; Antonopoulou A; Kollias S; Siasiakou S; Koronaios A; Zakynthinos S; Armaganidis A; Giamarellou H; Roussos C
    Clin Exp Immunol; 2005 Oct; 142(1):62-7. PubMed ID: 16178857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated oral and systemic levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in periodontitis.
    Bostanci N; Oztürk VÖ; Emingil G; Belibasakis GN
    J Dent Res; 2013 Feb; 92(2):161-5. PubMed ID: 23242230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease.
    Koussoulas V; Vassiliou S; Demonakou M; Tassias G; Giamarellos-Bourboulis EJ; Mouktaroudi M; Giamarellou H; Barbatzas C
    Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):375-9. PubMed ID: 16538108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
    Tomita H; Ogawa F; Hara T; Yanaba K; Iwata Y; Muroi E; Yoshizaki A; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response.
    Tejera A; Santolaria F; Diez ML; Alemán-Valls MR; González-Reimers E; Martínez-Riera A; Milena-Abril A
    Cytokine; 2007 Jun; 38(3):117-23. PubMed ID: 17659879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections.
    Phua J; Koay ES; Zhang D; Tai LK; Boo XL; Lim KC; Lim TK
    Eur Respir J; 2006 Oct; 28(4):695-702. PubMed ID: 16837506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity.
    Saurer L; Rihs S; Birrer M; Saxer-Seculic N; Radsak M; Mueller C;
    J Crohns Colitis; 2012 Oct; 6(9):913-23. PubMed ID: 22410349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prognostic value of the sTREM-1 plasma values in patients with sepsis: a cohort study].
    Latour-Pérez J; Alcalá-López A; García-García MA; Sánchez-Hernández JF; Abad-Terrado C; Viedma-Contreras JA; Masiá-Canuto M; Broch-Porcar MJ; Arizo-León D; González-Tejera M; Bonilla-Rovira F; Gutiérrez F
    Med Intensiva; 2010 May; 34(4):231-6. PubMed ID: 20096962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory response syndrome.
    Latour-Pérez J; Alcalá-López A; García-García MA; Sánchez-Hernández JF; Abad-Terrado C; Viedma-Contreras JA; Masiá M; González-Tejera M; Arizo-León D; Porcar MJ; Bonilla-Rovira F; Gutiérrez F
    Clin Biochem; 2010 Jun; 43(9):720-4. PubMed ID: 20303344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease.
    Tzivras M; Koussoulas V; Giamarellos-Bourboulis EJ; Tzivras D; Tsaganos T; Koutoukas P; Giamarellou H; Archimandritis A
    World J Gastroenterol; 2006 Jun; 12(21):3416-9. PubMed ID: 16733861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monocytes as a site of production of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in the septic host.
    Plachouras D; Routsi C; Giamarellos-Bourboulis EJ; Spyridaki E; Andrianakis I; Metzelopoulos S; Tsaganos T; Floros I; Douzinas EE; Armaganidis A; Roussos C; Giamarellou H
    Scand J Infect Dis; 2006; 38(10):909-15. PubMed ID: 17008237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic value of soluble triggering receptor expressed on myeloid cells in paediatric sepsis: a systematic review.
    Pontrelli G; De Crescenzo F; Buzzetti R; Calò Carducci F; Jenkner A; Amodio D; De Luca M; Chiurchiù S; Davies EH; Simonetti A; Ferretti E; Della Corte M; Gramatica L; Livadiotti S; Rossi P
    Ital J Pediatr; 2016 Apr; 42():44. PubMed ID: 27116911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can sTREM-1 predict septic shock & death in late-onset neonatal sepsis? A pilot study.
    Arízaga-Ballesteros V; Alcorta-García MR; Lázaro-Martínez LC; Amézquita-Gómez JM; Alanís-Cajero JM; Villela L; Castorena-Torres F; Lara-Díaz VJ
    Int J Infect Dis; 2015 Jan; 30():27-32. PubMed ID: 25461656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict risk profile, response to antimicrobial therapy, and development of complications in patients with chemotherapy-associated febrile neutropenia: a pilot study.
    Kwofie L; Rapoport BL; Fickl H; Meyer PW; Rheeder P; Hlope H; Anderson R; Tintinger GR
    Ann Hematol; 2012 Apr; 91(4):605-11. PubMed ID: 21976106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive value of serial measurements of sTREM-1 in the treatment response of patients with community-acquired pneumonia.
    Chao WC; Wang CH; Chan MC; Chow KC; Hsu JY; Wu CL
    J Formos Med Assoc; 2007 Mar; 106(3):187-95. PubMed ID: 17389162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum kinetics of soluble triggering receptor expressed on myeloid cells-1 differs in relation to the type of arthroplasty.
    Chatziantoniou I; Giamarellos-Bourboulis EJ; Diakos G; Lallos SN; Tsaganos T; Korres DS; Efstathopoulos NE
    Biomarkers; 2011 Nov; 16(7):600-4. PubMed ID: 21942576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical and laboratory criteria for identification of early-onset stroke associated pneumonia: a prospective trial].
    Xie J; Lu YM; Long W; He MZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jan; 23(1):24-7. PubMed ID: 21251362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.